Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Titan Medical developed the Enos single-port robotic surgical system aimed at improving minimally invasive procedures with reduced trauma and faster recovery. Due to financial constraints and inability to commercialize its technology independently, the company ceased R&D operations in mid–2023 and shifted to licensing its intellectual property. In early 2024, it entered a reverse takeover agreement with Conavi Medical. The combined entity will focus on Conavi’s Novasight Hybrid System for cardiovascular imaging rather than continuing Titan’s original robotics program.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Titan Medical.